Temporal Bone Osteoradionecrosis After Surgery and Radiotherapy for Malignant Parotid Tumors

被引:27
作者
Leonetti, John P. [1 ]
Marzo, Sam J. [1 ]
Zender, Chad A. [1 ]
Porter, Ryan G. [1 ]
Melian, Edward [2 ]
机构
[1] Loyola Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Dept Radiat Oncol, Maywood, IL 60153 USA
关键词
Malignant parotid tumors; Osteoradionecrosis; Radiation therapy; Temporal bone; MAJOR SALIVARY-GLANDS; MANAGEMENT; CARCINOMA;
D O I
10.1097/MAO.0b013e3181d8d6e1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the incidence of osteoradionecrosis (ORN) of the temporal bone after surgery with radiotherapy for malignant parotid tumors. Setting: A tertiary care, academic medical center. Patients: All patients who underwent surgical resection with postoperative radiotherapy (RT) for a malignant parotid tumor between July 1988 and July 2007. Interventions: A retrospective chart analysis to determine the extent of surgery, the RT parameters, and the incidence of ORN of the temporal bone. Main Outcome Measures: The incidence of ORN in 3 subgroups of patients. Results: The 221 patients with malignant parotid tumors who underwent surgical resection with postoperative RT were divided into groups 1, parotidectomy only; 2, parotidectomy with mastoidectomy; and 3, parotidectomy with subtotal petrosectomy. The overall incidence of temporal bone ORN in group 1 was 2 (2%) of 106; in group 2, 8 (13%) of 64; and in group 3, 0 (0%) of 51. Conclusion: The incidence of temporal bone ORN is higher after mastoidectomy for facial nerve identification or resection in patients undergoing parotidectomy with postoperative radiotherapy. Oversew of the ear canal with mastoid obliteration should be considered in this subgroup of patients to avoid this long-term complication of radiotherapy used in the treatment of malignant parotid tumors.
引用
收藏
页码:656 / 659
页数:4
相关论文
共 9 条
  • [1] Otological toxicity after postoperative radiotherapy for parotid tumours
    Bhide, S. A.
    Harrington, K. J.
    Nutting, C. M.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (01) : 77 - 82
  • [2] SURGICAL-MANAGEMENT OF OSTEORADIONECROSIS OF THE TEMPORAL BONE
    KVETON, JF
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1988, 98 (03) : 231 - 234
  • [3] Leonetti JP, 1997, AM J OTOL, V18, P223
  • [4] SUBTOTAL PETROSECTOMY IN THE MANAGEMENT OF ADVANCED PAROTID NEOPLASMS
    LEONETTI, JP
    SMITH, PG
    ANAND, VK
    KLETZKER, GR
    HARTMAN, JM
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1993, 108 (03) : 270 - 276
  • [5] MATSUBA HM, 1985, LARYNGOSCOPE, V95, P1059
  • [6] MURRAY CG, 1980, INT J RADIAT ONCOL, V6, P540
  • [7] CARCINOMA OF THE MAJOR SALIVARY-GLANDS TREATED BY SURGERY OR SURGERY PLUS POSTOPERATIVE RADIOTHERAPY
    NORTH, CA
    LEE, DJ
    PIANTADOSI, S
    ZAHURAK, M
    JOHNS, ME
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1990, 18 (06): : 1319 - 1326
  • [8] SPIRO RH, 1989, ARCH OTOLARYNGOL, V115, P316
  • [9] Hyperbaric oxygen in the therapeutic management of osteoradionecrosis of the facial bones
    Vudiniabola, S
    Pirone, C
    Williamson, J
    Goss, AN
    [J]. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2000, 29 (06) : 435 - 438